Department of Clinical Immunology and Internal Medicine, Hôpitaux Universitaires de Strasbourg et Université de Strasbourg, CNRS UPR9021, Strasbourg, France.
J Autoimmun. 2011 Feb;36(1):25-32. doi: 10.1016/j.jaut.2010.10.002. Epub 2010 Nov 13.
Common variable immunodeficiency (CVID) is the most frequent clinically expressed primary immunodeficiency in adults and is characterized by primary defective immunoglobulin production. Besides recurrent infectious manifestations, up to 20% of CVID patients develop autoimmune complications. In this study, we took advantages of the French DEFI database to investigate possible correlations between peripheral lymphocyte subpopulations and autoimmune clinical expression in CVID adult patients. In order to analyse homogeneous populations of patients with precise clinical phenotypes, we first focused on patients with autoimmune cytopenia because they represent prototypic autoantibody mediated diseases. In a secondary analysis, we have tested our conclusions including all "autoimmune" CVID patients. We describe one of the largest European studies with 311 CVID patients, including 55 patients with autoimmune cytopenia and 61 patients with clinical or serologic autoimmune expression, excluding autoimmune cytopenia. We clarify previous reports and we confirm a very significant correlation between an increased proportion of CD21(low) B cells and CVID associated autoimmune cytopenia, but independently of the presence of other autoimmune disorders or of splenomegaly. Moreover, in CVID associated autoimmune cytopenia, T cells display an activated phenotype with an increase of HLA-DR and CD95 expression and a decrease in the naïve T cell numbers. Patients with other autoimmune manifestations do not harbour this "T and B cells phenotypic picture". In view of recent findings on CD21(low) B cells in CVID and RA, we suggest that both a restricted subset of B cells and a T cell help are required for a breakdown of B cell tolerance against membrane auto antigens in CVID.
普通变异性免疫缺陷症(CVID)是成人中最常见的临床表达原发性免疫缺陷症,其特征是主要免疫球蛋白产生缺陷。除了反复发生的感染表现外,高达 20%的 CVID 患者会出现自身免疫并发症。在这项研究中,我们利用法国 DEFI 数据库研究了 CVID 成年患者外周淋巴细胞亚群与自身免疫临床表型之间的可能相关性。为了分析具有精确临床表型的同质患者群体,我们首先关注自身免疫性血细胞减少症患者,因为他们代表了典型的自身抗体介导的疾病。在二次分析中,我们对所有“自身免疫性”CVID 患者进行了测试。我们描述了一项规模最大的欧洲研究,共纳入 311 例 CVID 患者,其中 55 例为自身免疫性血细胞减少症患者,61 例为有临床或血清学自身免疫表达而无自身免疫性血细胞减少症患者。我们澄清了以前的报告,并证实 CD21(low)B 细胞比例增加与 CVID 相关的自身免疫性血细胞减少症之间存在非常显著的相关性,且与其他自身免疫性疾病或脾肿大的存在无关。此外,在 CVID 相关的自身免疫性血细胞减少症中,T 细胞表现出激活表型,其 HLA-DR 和 CD95 表达增加,而幼稚 T 细胞数量减少。其他自身免疫表现的患者不存在这种“T 和 B 细胞表型”。鉴于最近在 CVID 和 RA 中发现的 CD21(low)B 细胞,我们认为,在 CVID 中,针对膜自身抗原的 B 细胞耐受的破坏需要受限的 B 细胞亚群和 T 细胞辅助。